whitepaper ebook: Vaccines in the digital age 11 February 2021 | By IDBS In this ebook, we’ll see how digitally enabling your organisation can increase capacity and improve vaccine production.
news Researchers discover factor that triggers muscle stem cells to heal 11 February 2021 | By Victoria Rees (Drug Target Review) In a zebrafish model, researchers have found that the protein NAPMT can trigger muscle stem cells to proliferate and heal muscle damage.
news CRISPR used to model acute myeloid leukaemia progression 11 February 2021 | By Victoria Rees (Drug Target Review) CRISPR-Cas9 and stem cell technologies have been used to create a cellular model of acute myeloid leukaemia, revealing therapeutic targets.
whitepaper Whitepaper: Automated cell culture and screening 8 February 2021 | By Ncardia This whitepaper describes the automated culturing of hiPSC-derived cells for high-throughput phenotypic screening, using validated phenotypic assays.
news Flaw found in lab models used to study human blood-brain barrier 8 February 2021 | By Victoria Rees (Drug Target Review) Researchers have uncovered a flaw in lab models used to study the human blood-brain barrier and a potential strategy to correct the error.
news Stem cell study illuminates cause of dilated cardiomyopathy (DCM) 2 February 2021 | By Victoria Rees (Drug Target Review) A study using stem cells has revealed that DCM-causing mutations in LMNA disrupt the organisation of DNA in the nucleus of heart muscle cells.
article Preventing stem cells from transforming into pre-leukaemia stem cells 1 February 2021 | By Victoria Rees (Drug Target Review) Researchers have discovered that two enzymes called APOBEC3C and ADAR1 work together to fuel the transition from pre-cancer stem cells to cancer stem cells in leukaemia.
whitepaper Whitepaper: Why BioPharma Lifecycle Management? 28 January 2021 | By IDBS In this whitepaper we explore some of the major bottlenecks in the development lifecycle and the current barriers to effective digital transformation.
news In vitro model could aid the development of fatty liver disease treatments 26 January 2021 | By Hannah Balfour (Drug Target Review) The patient-derived model of non-alcoholic fatty liver disease (NAFLD) accurately reproduced the complex human metabolic pathways involved in the development of the disease.
news Scientists develop potential ‘smart’ stem cells made from human fat 21 January 2021 | By Victoria Rees (Drug Target Review) Using a new compound mixture, researchers have created adaptive and regenerative stem cells from human fat cells.
whitepaper ebook: The organoid culture handbook 21 January 2021 | By Bio-Techne This tissue-specific handbook brings you key publications, in-house protocols and troubleshooting recommendations for your organoid cell culture.
news New tissue engineering process brings laboratory-grown organs one step closer 19 January 2021 | By Hannah Balfour (Drug Target Review) Researchers have developed a new technique that that could one day enable us to grow fully functional human organs in the laboratory.
news Novel human alveolar tissue model could help COVID-19 drug development 12 January 2021 | By Hannah Balfour (Drug Target Review) Researchers will use the in vitro model to study how respiratory viruses, like SARS-CoV-2, cause Acute Respiratory Distress Syndrome (ARDS) and develop potential interventions.
news Brain injury may drive the development of cancer 5 January 2021 | By Hannah Balfour (Drug Target Review) A new study reveals that the healing process following a brain injury could initiate the growth of glioblastoma cancers.
news New embryonic stem cell type could advance regenerative medicine 7 December 2020 | By Hannah Balfour (Drug Target Review) Scientists suggest that research using XPSCs, an intermediate form of embryonic stem cell, could help accelerate the development of stem cell-derived tissues and organs for transplantation.
